Longevity biotech (LongBio) is the future of medicine. On Sunday, we cover the state of the investment landscape in longevity.
Agenda:
11:00 am: Opening remarks
11:05 am: Applying synthetic biology to treat the hallmarks of aging, by Yu Wang
11:30 am: From Video Game Founder to Longevity Investor - Our War against the Dragon-Tyrant, by Wang Boyang (Immortal Dragons)
11:55 am: Building and Investing In Longevity Biotech (LongBio) and the Future of Medicine, by Sebastian Brunemeier (Healthspan Capital)
12:20 pm: What’s wrong with longevity?, by Denisa Lepadatu (Apollo Health Ventures)
12:45 pm: Fundraising from a founder's perspective, by Boris Djordjevic (199 Bio)
13:10 pm: Panel: How can geroscience attract more investment?, by the above speakers
For more information on the broader series of events covering longevity biotech topics, check out the LuMa page.
.
.
.
Many thanks to our sponsor:
